Epithelial Ovarian Cancer: A Five Year Review

202337 citationsReviewgold Open Access

Authors

Christos Arnaoutoglou · Papageorgiou General Hospital

Kalliopi Dampala · Aristotle University of Thessaloniki

Christos Anthoulakis · Aristotle University of Thessaloniki

Evangelos Papanikolaou · Aristotle University of Thessaloniki

Ioannis Tentas

Georgios Dragoutsos · Democritus University of Thrace

Nikolaos Machairiotis · Ealing Hospital

Abstract

Ovarian cancer is a malignant disease that affects thousands of patients every year. Currently, we use surgical techniques for early-stage cancer and chemotherapy treatment combinations for advanced stage cancer. Several novel therapies are currently being investigated, with gene therapy and stem cell therapy being the corner stone of this investigation. We conducted a thorough search on PubMed and gathered up-to-date information regarding epithelial ovarian cancer therapies. We present, in the current review, all novel treatments that were investigated in this field over the past five years, with a particular focus on local treatment.

Topics & Keywords

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Toxin Mechanisms and Immunotoxins

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Medicina

Volume 59, Issue 7, pp. 1183-1183

DOI: 10.3390/medicina59071183

Field-Weighted Citation Impact: 9.94